Literature DB >> 18987159

Cell cycle control of pituitary development and disease.

Victor Quereda1, Marcos Malumbres.   

Abstract

The pituitary gland regulates diverse physiological functions, including growth, metabolism, reproduction, stress response, and ageing. Early genetic models in the mouse taught us that the pituitary is highly sensitive to genetic alteration of specific cell cycle regulators such as the retinoblastoma protein (pRB) or the cell cycle inhibitor p27(Kip1). The molecular analysis of human pituitary neoplasias has now corroborated that cell cycle deregulation is significantly implicated in pituitary tumorigenesis. In particular, proteins involved in cyclin-dependent kinase regulation or the pRB pathway are altered in nearly all human pituitary tumors. Additional cell cycle regulators such as PTTG1/securin may have critical roles in promoting genomic instability in pituitary neoplasias. Recent experimental data suggest that these cell cycle regulators may have significant implications in the biology of putative progenitor cells and pituitary homeostasis. Understanding how cell cycle regulation controls pituitary biology may provide us with new therapeutic approaches against pituitary diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18987159     DOI: 10.1677/JME-08-0146

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  32 in total

1.  p19Ink4d is a tumor suppressor and controls pituitary anterior lobe cell proliferation.

Authors:  Feng Bai; Ho Lam Chan; Matthew D Smith; Hiroaki Kiyokawa; Xin-Hai Pei
Journal:  Mol Cell Biol       Date:  2014-03-31       Impact factor: 4.272

2.  Lhx4 deficiency: increased cyclin-dependent kinase inhibitor expression and pituitary hypoplasia.

Authors:  Peter Gergics; Michelle L Brinkmeier; Sally A Camper
Journal:  Mol Endocrinol       Date:  2015-02-10

Review 3.  Pituitary gland development and disease: from stem cell to hormone production.

Authors:  Shannon W Davis; Buffy S Ellsworth; María Inés Peréz Millan; Peter Gergics; Vanessa Schade; Nastaran Foyouzi; Michelle L Brinkmeier; Amanda H Mortensen; Sally A Camper
Journal:  Curr Top Dev Biol       Date:  2013       Impact factor: 4.897

4.  P21Waf1/Cip1 and p27Kip1 are correlated with the development and invasion of prolactinoma.

Authors:  Wei Dong; Jianhua Li; Qian Liu; Chunhui Liu; Chuzhong Li; Guidong Song; Haibo Zhu; Hua Gao; Yazhuo Zhang
Journal:  J Neurooncol       Date:  2017-12-11       Impact factor: 4.130

5.  p21, an important mediator of quiescence during pituitary tumor formation, is dispensable for normal pituitary development during embryogenesis.

Authors:  Pamela Monahan; Ashley D Himes; Agata Parfieniuk; Lori T Raetzman
Journal:  Mech Dev       Date:  2011-12-01       Impact factor: 1.882

6.  Expression of cell growth negative regulators MEG3 and GADD45γ is lost in most sporadic human pituitary adenomas.

Authors:  Lisiane Cervieri Mezzomo; Paulo Henrique Gonzales; Frederico Giacomoni Pesce; Nélson Kretzmann Filho; Nelson Pires Ferreira; Miriam Costa Oliveira; Maria Beatriz Fonte Kohek
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

7.  Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor.

Authors:  Ning-Ai Liu; Hong Jiang; Anat Ben-Shlomo; Kolja Wawrowsky; Xue-Mo Fan; Shuo Lin; Shlomo Melmed
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-02       Impact factor: 11.205

8.  Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states.

Authors:  Sunita K Agarwal; Carmen M Mateo; Stephen J Marx
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

9.  Proteomic analysis of prolactinoma cells by immuno-laser capture microdissection combined with online two-dimensional nano-scale liquid chromatography/mass spectrometry.

Authors:  Yingchao Liu; Jinsong Wu; Guoquan Yan; Ruiping Hou; Dongxiao Zhuang; Luping Chen; Qi Pang; Jianhong Zhu
Journal:  Proteome Sci       Date:  2010-01-29       Impact factor: 2.480

10.  HMGA2 cooperates with either p27kip1 deficiency or Cdk4R24C mutation in pituitary tumorigenesis.

Authors:  Monica Fedele; Orlando Paciello; Davide De Biase; Mario Monaco; Gennaro Chiappetta; Michela Vitiello; Antonio Barbieri; Domenica Rea; Antonio Luciano; Serenella Papparella; Claudio Arra; Alfredo Fusco
Journal:  Cell Cycle       Date:  2018-01-30       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.